Martin Cloutier

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Attention Deficit Hyperactivity Disorder

Autism Spectrum Disorder

Top Venues

Journal of comparative effectiveness research

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics 27 (1) (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics 27 (1) (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research (2024)
Jeff Schein, Martin Cloutier, Rebecca L Bungay, Marjolaine Gauthier-Loiselle, Ann C Childress
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder. Journal of medical economics (2024)
Jeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Chunyi Xu, Alice Qu, Francesca Lee, Ann Childress
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy. Journal of comparative effectiveness research 13 (9) (2024)
William Wong, Yeun Mi Yim, Ashley Kim, Martin Cloutier, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, Annie Guerin
Assessment of costs associated with adverse events in patients with cancer. PloS one 13 (4) (2018)